Abstract
Polymorphonuclear leukocytes (neutrophils) form the first line of defence in humans. After activation, they migrate through vessel walls toward the invading agent. The intruding pathogens are eliminated through the action of released proteases and by production of reactive oxygen species (ROS). Histamine, a biogenic amine with various physiological and pathological effects, is known to modulate the immune response of neutrophils, e.g., it blunts the production of ROS in neutrophils after binding to the histamine-2 receptor. To detect the ROS in neutrophils, various methods are used. Among these, luminophore-enhanced chemiluminescence is a very sensitive and easy tool for studying the effects of various compounds on ROS production in neutrophils. On the other hand, its selectivity is questionable. However, employing cell-free systems producing selective ROS types, the inhibitory effects of tested compounds against distinct ROS may be evaluated. In this chapter, we describe the methods for the evaluation of ROS modulating effects of histamine agonists/antagonists in human neutrophils by using chemiluminescence methods.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Leurs R, Vischer HF, Wijtmans M et al (2011) En route to new blockbuster anti-histamines: surveying the offspring of the expanding histamine receptor family. Trends Pharmacol Sci 32:250–257
Alcaniz L, Vega A, Chacon P et al (2013) Histamine production by human neutrophils. FASEB J 27:2902–2910
Huang JF, Thurmond RL (2008) The new biology of histamine receptors. Curr Allergy Asthma Rep 8:21–27
Shahid M, Walker GB, Zorn SH et al (2009) Asenapine: a novel psychopharmacologic agent with a unique human receptor signature. J Psychopharmacol 23:65–73
Bury TB, Corhay JL, Radermecker MF (1992) Histamine-induced inhibition of neutrophil chemotaxis and T-lymphocyte proliferation in man. Allergy 47:624–629
O’Reilly M, Alpert R, Jenkinson S et al (2002) Identification of a histamine H4 receptor on human eosinophils—role in eosinophil chemotaxis. J Recept Signal Transduct Res 22:431–448
Vasicek O, Lojek A, Jancinova V et al (2014) Role of histamine receptors in the effects of histamine on the production of reactive oxygen species by whole blood phagocytes. Life Sci 100:67–72
Oda T, Morikawa N, Saito Y et al (2000) Molecular cloning and characterization of a novel type of histamine receptor preferentially expressed in leukocytes. J Biol Chem 275:36781–36786
Morse KL, Behan J, Laz TM et al (2001) Cloning and characterization of a novel human histamine receptor. J Pharmacol Exp Ther 296:1058–1066
Zhu Y, Michalovich D, Wu H et al (2001) Cloning, expression, and pharmacological characterization of a novel human histamine receptor. Mol Pharmacol 59:434–441
Melmon KL, Khan MM (1987) Histamine and its lymphocyte-selective derivatives as immune modulators. Trends Pharmacol Sci 8:437–441
Azuma Y, Shinohara M, Wang PL et al (2001) Histamine inhibits chemotaxis, phagocytosis, superoxide anion production, and the production of TNFalpha and IL-12 by macrophages via H2-receptors. Int Immunopharmacol 1:1867–1875
Betten A, Dahlgren C, Hermodsson S et al (2003) Histamine inhibits neutrophil NADPH oxidase activity triggered by the lipoxin A4 receptor-specific peptide agonist Trp-Lys-Tyr-Met-Val-Met. Scand J Immunol 58:321–326
Lojek A, Ciz M, Pekarova M et al (2011) Modulation of metabolic activity of phagocytes by antihistamines. Interdiscip Toxicol 4:15–19
Liu SC, Chu YH, Kao CH et al (2015) Steroids and antihistamines synergize to inhibit rat’s airway smooth muscle contractility. Eur Arch Otorhinolaryngol 272(6):1443–1449
Scichilone N, Ventura MT, Bonini M et al (2015) Choosing wisely: practical considerations on treatment efficacy and safety of asthma in the elderly. Clin Mol Allergy 13(1):7
Leurs R, Church MK, Taglialatela M (2002) H1-antihistamines: inverse agonism, anti-inflammatory actions and cardiac effects. Clin Exp Allergy 32:489–498
Church MK, Church DS (2013) Pharmacology of antihistamines. Indian J Dermatol 58:219–224
Drabikova K, Nosal R, Jancinova V et al (2002) Reactive oxygen metabolite production is inhibited by histamine and H1-antagonist dithiaden in human PMN leukocytes. Free Radic Res 36:975–980
Jancinova V, Drabikova K, Nosal R et al (2006) Extra- and intracellular formation of reactive oxygen species by human neutrophils in the presence of pheniramine, chlorpheniramine and brompheniramine. Neuro Endocrinol Lett 27(Suppl 2):141–143
Ciz M, Lojek A (2013) Modulation of neutrophil oxidative burst via histamine receptors. Br J Pharmacol 170:17–22
Nosal R, Jancinova V, Drabikova K et al (2015) Molecular pharmacology of antihistamines in inhibition of oxidative burst of professional phagocytes. Gen Physiol Biophys 34:209–216
Drabikova K, Jancinova V, Nosal R et al (2006) Extra- and intracellular oxidant production in phorbol myristate acetate stimulated human polymorphonuclear leukocytes: modulation by histamine and H(1)-antagonist loratadine. Inflamm Res 55(Suppl 1):S19–S20
Nosal R, Drabikova K, Jancinova V et al (2006) On the pharmacology and toxicology of neutrophils. Neuro Endocrinol Lett 27(Suppl 2):148–151
Wright HL, Moots RJ, Bucknall RC et al (2010) Neutrophil function in inflammation and inflammatory diseases. Rheumatology (Oxford) 49:1618–1631
Kruger P, Saffarzadeh M, Weber AN et al (2015) Neutrophils: between host defence, immune modulation, and tissue injury. PLoS Pathog 11:e1004651
Serhan CN, Brain SD, Buckley CD et al (2007) Resolution of inflammation: state of the art, definitions and terms. FASEB J 21:325–332
Mocsai A, Walzog B, Lowell CA (2015) Intracellular signalling during neutrophil recruitment. Cardiovasc Res 107:373–385
Scapini P, Lapinet-Vera JA, Gasperini S et al (2000) The neutrophil as a cellular source of chemokines. Immunol Rev 177:195–203
Scapini P, Cassatella MA (2014) Social networking of human neutrophils within the immune system. Blood 124:710–719
Maderna P, Godson C (2003) Phagocytosis of apoptotic cells and the resolution of inflammation. Biochim Biophys Acta 1639:141–151
Serhan CN (2014) Pro-resolving lipid mediators are leads for resolution physiology. Nature 510:92–101
Jones DP (2006) Disruption of mitochondrial redox circuitry in oxidative stress. Chem Biol Interact 163:38–53
Halliwell B (2007) Biochemistry of oxidative stress. Biochem Soc Trans 35:1147–1150
Oktyabrsky ON, Smirnova GV (2007) Redox regulation of cellular functions. Biochemistry (Mosc) 72:132–145
Filippin LI, Vercelino R, Marroni NP et al (2008) Redox signalling and the inflammatory response in rheumatoid arthritis. Clin Exp Immunol 152:415–422
Babior BM (1999) NADPH oxidase: an update. Blood 93:1464–1476
Dahlgren C, Karlsson A (1999) Respiratory burst in human neutrophils. J Immunol Methods 232:3–14
Liu L, Dahlgren C, Elwing H et al (1996) A simple chemiluminescence assay for the determination of reactive oxygen species produced by human neutrophils. J Immunol Methods 192:173–178
Allen RC (1977) Evaluation of serum opsonic capacity by quantitating the initial chemiluminescent response from phagocytizing polymorphonuclear leukocytes. Infect Immun 15:828–833
Seymour GJ, Whyte GJ, Powell RN (1986) Chemiluminescence in the assessment of polymorphonuclear leukocyte function in chronic inflammatory periodontal disease. J Oral Pathol 15:125–131
Fromtling RA, Abruzzo GK (1985) Chemiluminescence as a tool for the evaluation of antimicrobial agents: a review. Methods Find Exp Clin Pharmacol 7:493–500
Calokerinos AC, Deftereos NT, Baeyens WR (1995) Chemiluminescence in drug assay. J Pharm Biomed Anal 13:1063–1071
Vilim V, Wilhelm J (1989) What do we measure by a luminol-dependent chemiluminescence of phagocytes? Free Radic Biol Med 6:623–629
Dahlgren C, Stendahl O (1983) Role of myeloperoxidase in luminol-dependent chemiluminescence of polymorphonuclear leukocytes. Infect Immun 39:736–741
Lundqvist H, Kricka LJ, Stott RA et al (1995) Influence of different luminols on the characteristics of the chemiluminescence reaction in human neutrophils. J Biolumin Chemilumin 10:353–359
Lundqvist H, Dahlgren C (1996) Isoluminol-enhanced chemiluminescence: a sensitive method to study the release of superoxide anion from human neutrophils. Free Radic Biol Med 20:785–792
Dahlgren C (1988) Effects on extra- and intracellularly localized, chemoattractant-induced, oxygen radical production in neutrophils following modulation of conditions for ligand-receptor interaction. Inflammation 12:335–349
Johansson A, Dahlgren C (1989) Characterization of the luminol-amplified light-generating reaction induced in human monocytes. J Leukoc Biol 45:444–451
Kopprasch S, Pietzsch J, Graessler J (2003) Validation of different chemilumigenic substrates for detecting extracellular generation of reactive oxygen species by phagocytes and endothelial cells. Luminescence 18:268–273
Kralova J, Nosal R, Drabikova K et al (2008) Comparative investigations of the influence of H1-antihistamines on the generation of reactive oxygen species by phagocytes. Inflamm Res 57(Suppl 1):S49–S50
Kralova J, Rackova L, Pekarova M et al (2009) The effects of H1-antihistamines on the nitric oxide production by RAW 264.7 cells with respect to their lipophilicity. Int Immunopharmacol 9:990–995
Nosal R, Drabikova K, Jancinova V et al (2009) H1-antihistamines and oxidative burst of professional phagocytes. Neuro Endocrinol Lett 30(Suppl 1):133–136
Droge W (2002) Free radicals in the physiological control of cell function. Physiol Rev 82:47–95
Kori S, Namiki H, Suzuki K (2009) Biphasic regulation of polymorphonuclear leukocyte spreading by polyphenolic compounds with pyrogallol moieties. Int Immunopharmacol 9:1159–1167
Dahlgren C, Karlsson A, Bylund J (2007) Measurement of respiratory burst products generated by professional phagocytes. Methods Mol Biol 412:349–363
Jancinova V, Drabikova K, Nosal R et al (2006) The combined luminol/isoluminol chemiluminescence method for differentiating between extracellular and intracellular oxidant production by neutrophils. Redox Rep 11:110–116
Kucekova Z, Humpolicek P, Kasparkova V et al (2014) Colloidal polyaniline dispersions: antibacterial activity, cytotoxicity and neutrophil oxidative burst. Colloids Surf B Biointerfaces 116:411–417
Komrskova D, Lojek A, Hrbac J et al (2006) A comparison of chemical systems for luminometric determination of antioxidant capacity towards individual reactive oxygen species. Luminescence 21:239–244
Acknowledgments
The study was supported by the MEYS of the Czech Republic (LD14030), Slovak Research and Development Agency (APVV-0052-10), and the Scientific Grant Agency of the Slovak Republic (VEGA 2/0029/16). OV and TP were supported by the project no. LQ1605 from the National Program of Sustainability II (MEYS CR) and by the project FNUSA-ICRC no. CZ.1.05/1.1.00/02.0123 (OP VaVpI).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer Science+Business Media LLC
About this protocol
Cite this protocol
Vašíček, O., Perečko, T., Jančinová, V., Pažoureková, S., Nosáľ, R., Číž, M. (2017). Chemiluminescence: A Sensitive Method for Detecting the Effects of Histamine Receptor Agonists/Antagonists on Neutrophil Oxidative Burst. In: Tiligada, E., Ennis, M. (eds) Histamine Receptors as Drug Targets. Methods in Pharmacology and Toxicology. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-6843-5_7
Download citation
DOI: https://doi.org/10.1007/978-1-4939-6843-5_7
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-6841-1
Online ISBN: 978-1-4939-6843-5
eBook Packages: Springer Protocols